UMIN ID: UMIN000054544
Registered date:01/10/2024
Clinical features and therapeutic response of thyroid associated ophthalmopathy during COVID-19 pandemic
Basic Information
Recruitment status | Complete: follow-up complete |
---|---|
Health condition(s) or Problem(s) studied | Thyroid associated ophthalmopathy |
Date of first enrollment | 2023/10/01 |
Target sample size | 60 |
Countries of recruitment | Japan |
Study type | Observational |
Intervention(s) |
Outcome(s)
Primary Outcome | Clinical features at diagnosis therapeutic response of clinical activity score and diplopia at 6 months after |
---|---|
Secondary Outcome |
Key inclusion & exclusion criteria
Age minimum | 20years-old |
---|---|
Age maximum | 90years-old |
Gender | Male and Female |
Include criteria | |
Exclude criteria | Patients who have indicated their refusal to participate in the study |
Related Information
Primary Sponsor | Tottori University |
---|---|
Secondary Sponsor | |
Source(s) of Monetary Support | Japan Society for the Promotion of Science |
Secondary ID(s) |
Contact
public contact | |
Name | Kazuhiko Matsuzawa |
Address | Nishi-cho36-1, Yonago, Tottori 683-8504 |
Telephone | +81-859-38-6517 |
k.matsuzawa@tottori-u.ac.jp | |
Affiliation | Tottori University Faculty of Medicine Division of Pharmacology |
scientific contact | |
Name | Kazuhiko Matsuzawa |
Address | Nishi-cho36-1, Yonago, Tottori |
Telephone | +81-859-38-6517 |
k.matsuzawa@tottori-u.ac.jp | |
Affiliation | Tottori University Faculty of Medicine Division of Pharmacology |